Benjamin Stone
Förmögenhet: 275 502 $ per 2026-05-31
Förmögenhet: 275 502 $ per 2026-05-31
Benjamin Stone is the founder of IconOVir Bio, Inc.,76Bio, Inc. Mr. Stone currently holds the position of Chief Business Officer at AnaptysBio, Inc. since 2022.
Mr. Stone also serves as Chief Business Officer at First Tracks Biotherapeutics, Inc. Mr. Stone completed undergraduate education at the University of Pennsylvania and The Wharton School of the University of Pennsylvania.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
0,05 % | 2026-05-12 | 17 262 ( 0,05 % ) | 275 502 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| ANAPTYSBIO, INC. | Företagsledare/Principal | 2022-01-01 |
| Företag | Position | Slut |
|---|---|---|
IconOVir Bio, Inc.
IconOVir Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops oncolytic virus therapy to improve the treatment of patients with cancer | Grundare | - |
76bio, Inc.
76bio, Inc. Pharmaceuticals: MajorHealth Technology Develops transformational therapies for patients with life-threatening disease | Grundare | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
AnaptysBio, Inc.
AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IconOVir Bio, Inc.
IconOVir Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops oncolytic virus therapy to improve the treatment of patients with cancer | Health Technology |
76bio, Inc.
76bio, Inc. Pharmaceuticals: MajorHealth Technology Develops transformational therapies for patients with life-threatening disease | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån